Items where authors include "Goetz, M.P."

Article

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (8 more authors) (2025) ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer. Future Oncology, 21 (11). pp. 1317-1324. ISSN 1479-6694

Kittaneh, M., Badve, S., Caldera, H. et al. (12 more authors) (2020) Case-based review and olinical guidance on the use of genomic assays for early-stage breast cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical Breast Cancer, 20 (3). pp. 183-193. ISSN 1526-8209

Abraham, J., Caldera, H., Coleman, R. et al. (11 more authors) (2018) Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast Cancer Research and Treatment, 169 (1). pp. 1-7. ISSN 0167-6806

Proceedings Paper

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (17 more authors) (2024) Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .